Search Thermo Fisher Scientific
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Bentracimab is a monoclonal antibody developed to reverse the antiplatelet effects of ticagrelor in patients experiencing major bleeding or requiring urgent surgery. Clinical studies have shown it can safely and effectively mitigate bleeding complications associated with ticagrelor. (Managed Healthcare Executive)
仅用于科研。不用于诊断过程。未经明确授权不得转售。